# SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

> **NCT06389097** · — · RECRUITING · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 80 (estimated)

## Conditions studied

- Prostate Cancer
- Advanced Cancer

## Interventions

- **RADIATION:** Radium-223
- **RADIATION:** 177Lu-DOTATATE
- **RADIATION:** 177Lu-PSMA-617

## Key facts

- **NCT ID:** NCT06389097
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-03
- **Primary completion:** 2028-11
- **Final completion:** 2029-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06389097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06389097, "SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06389097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*